(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ Composite: ARCT) rose 5.33% to $37.43 at 14:39 EST on Tuesday, following the last session’s downward trend. NASDAQ Composite is rising 0.79% to $15,979.78, following the last session’s downward trend. This seems, so far, a somewhat up trend trading session today.

Arcturus Therapeutics’s last close was $35.53, 72.61% below its 52-week high of $129.71.


Today’s last reported volume for Arcturus Therapeutics is 218827 which is 55.99% below its average volume of 497252.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is 625.3% for the present quarter and 1814.2% for the next. The company’s growth estimates for the ongoing quarter is a negative 72.8% and positive 6.4% for the next.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.


Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.28%, a negative 1.05%, and a positive 3.66%, respectively.

Arcturus Therapeutics’s highest amplitude of average volatility was 3.88% (last week), 3.49% (last month), and 3.66% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be oversold (<=20).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $37.43 at 14:39 EST, way below its 52-week high of $129.71 and way higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s worth is way below its 50-day moving average of $44.81 and under its 200-day moving average of $40.32.

More news about Arcturus Therapeutics (ARCT).


Please enter your comment!
Please enter your name here